3 Factor Indexing’s DexCom DXCM Stock Holding History

3 Factor Indexing’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135	Hold	2	–	–	﹤0.01%	358
2026 Q1	$126	Buy	+2	New	+$139	﹤0.01%	365

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

3 Factor Indexing's DXCM Position: Q2 2026 in Review

3 Factor Indexing held its DexCom (DXCM) position steady in Q2 2026 at 2 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #358.

3 Factor Indexing first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

3 Factor Indexing held 2 shares of DexCom worth $135 as of Q2 2026.
3 Factor Indexing left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #358 holding.
3 Factor Indexing first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.